Component
Protocolized caloric restriction during ICU refeeding-syndrome management
Protocolized caloric restriction during ICU refeeding-syndrome management. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Days alive after ICU discharge did not differ significantly: 44.8 versus 39.9 days, estimated difference 4.9 days (95% CI −2.3 to 13.6), p=0.19.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/phosphorus-research/26597128.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6", "start_char": 0, "end_char": 2574, "text_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6"}
- experimental_model
- Multicenter randomized clinical management trial
- exposure
- Protocolized caloric restriction versus continued standard feeding during electrolyte replacement; 60-day follow-up
- limitations
- Management-strategy trial, not isolated phosphate supplementation. Primary composite endpoint was nonsignificant; component results must retain that context.
- nutrient_topic
- Phosphorus research collection; topical membership is not evidence of a direct dietary effect. · Phosphorus
- organism
- Human
- plain_language
- The trial’s primary composite outcome was not statistically significant.
- primary_references
- [phosphorus-p26597128] Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. (2015). https://pubmed.ncbi.nlm.nih.gov/26597128/ DOI: 10.1016/s2213-2600(15)00418-x
- tissue_or_cell_type
- 339 critically ill adults developing refeeding syndrome within 72 hours of nutrition
Phosphorus: metabolism, signaling and nutrient connections (2026-09-17) · lines 1154–1165
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Multicenter randomized clinical management trial · source_derived_draft · unverified_draft
### phosphorus-refeeding-primary Days alive after ICU discharge did not differ significantly: 44.8 versus 39.9 days, estimated difference 4.9 days (95% CI −2.3 to 13.6), p=0.19. Condition category: normal nutrient_topic: Phosphorus research collection; topical membership is not evidence of a direct dietary effect. plain_language: The trial’s primary composite outcome was not statistically significant. organism: Human tissue_or_cell_type: 339 critically ill adults developing refeeding syndrome within 72 hours of nutrition experimental_model: Multicenter randomized clinical management trial limitations: Management-strategy trial, not isolated phosphate supplementation. Primary composite endpoint was nonsignificant; component results must retain that context. exposure: Protocolized caloric restriction versus continued standard feeding during electrolyte replacement; 60-day follow-up evidence_span: {"source_cache": "artifacts/phosphorus-research/26597128.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6", "start_char": 0, "end_char": 2574, "text_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6"} [phosphorus-p26597128] Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. (2015). https://pubmed.ncbi.nlm.nih.gov/26597128/ DOI: 10.1016/s2213-2600(15)00418-x
Complete structured claim and evidenceA component analysis found 149/164 participants alive at day 60 with restriction versus 128/163 with standard feeding, p=0.002.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/phosphorus-research/26597128.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6", "start_char": 0, "end_char": 2574, "text_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6"}
- experimental_model
- Multicenter randomized clinical management trial
- exposure
- Protocolized caloric restriction versus continued standard feeding during electrolyte replacement; 60-day follow-up
- limitations
- Management-strategy trial, not isolated phosphate supplementation. Primary composite endpoint was nonsignificant; component results must retain that context.
- nutrient_topic
- Phosphorus research collection; topical membership is not evidence of a direct dietary effect. · Phosphorus
- organism
- Human
- plain_language
- The survival component favored the supervised strategy, while the primary composite remained nonsignificant.
- primary_references
- [phosphorus-p26597128] Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. (2015). https://pubmed.ncbi.nlm.nih.gov/26597128/ DOI: 10.1016/s2213-2600(15)00418-x
- tissue_or_cell_type
- 339 critically ill adults developing refeeding syndrome within 72 hours of nutrition
Phosphorus: metabolism, signaling and nutrient connections (2026-09-17) · lines 1167–1178
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Multicenter randomized clinical management trial · source_derived_draft · unverified_draft
### phosphorus-refeeding-survival A component analysis found 149/164 participants alive at day 60 with restriction versus 128/163 with standard feeding, p=0.002. Condition category: normal nutrient_topic: Phosphorus research collection; topical membership is not evidence of a direct dietary effect. plain_language: The survival component favored the supervised strategy, while the primary composite remained nonsignificant. organism: Human tissue_or_cell_type: 339 critically ill adults developing refeeding syndrome within 72 hours of nutrition experimental_model: Multicenter randomized clinical management trial limitations: Management-strategy trial, not isolated phosphate supplementation. Primary composite endpoint was nonsignificant; component results must retain that context. exposure: Protocolized caloric restriction versus continued standard feeding during electrolyte replacement; 60-day follow-up evidence_span: {"source_cache": "artifacts/phosphorus-research/26597128.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6", "start_char": 0, "end_char": 2574, "text_sha256": "0324ddb02d92a61886682e682350e42356a4596c93e3ff60d23860163c6c1aa6"} [phosphorus-p26597128] Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. (2015). https://pubmed.ncbi.nlm.nih.gov/26597128/ DOI: 10.1016/s2213-2600(15)00418-x
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.